MiratiFul Nail Fungus Treatment

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: MiratiFul Nail Fungus Treatment
Generic name: TOLNAFTATE
Manufacturer: Texas MiratiFul Enterprises Inc.
Product type: HUMAN OTC DRUG
SPL set ID: 35eb20e3-86d4-4bec-b572-3d5fe86ac74d
SPL ID: 58295d84-4d47-3613-e063-6394a90a1fd6
Version: 2
Effective date: 2026-08-03
Source export date: 2026-09-28
Source partition: 14
Source file: https://download.open.fda.gov/drug/label/drug-label-0014-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/db99fd80353afecef4949b48edcaa018be72b966b2360184251eb14df43743f9/drug-label-0014-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:41:29

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		MiratiFul Nail Fungus Treatment	openfda.brand_name
generic name		TOLNAFTATE	openfda.generic_name
manufacturer name		Texas MiratiFul Enterprises Inc.	openfda.manufacturer_name
ndc	package	87885-001-01	openfda.package_ndc
ndc	product	87885-001	openfda.product_ndc
ndc11	package	87885000101	derived:openfda.package_ndc
rxcui		313423	openfda.rxcui
spl id		58295d84-4d47-3613-e063-6394a90a1fd6	id
spl set id		35eb20e3-86d4-4bec-b572-3d5fe86ac74d	set_id
unii		06KB629TKV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings ▪ For external use only. ▪ Avoid contact with the eyes. ▪ Do not use on children under 2 years of age unless directed by a doctor. ▪ Keep this and all drugs out of the reach of children. ▪ If treating athlete’s foot and ringworm: If irritation occurs or if there is no improvement within 4 weeks, discontinue use and consult a doctor. ▪ If treating jock itch: If irritation occurs or if there is no improvement within 2 weeks, discontinue use and consult a doctor. ▪ If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.